Top 9 Biotechnology companies in Italy
This curated ranking covers the 9 largest biotechnology companies in Italy, ordered by estimated audience size from Rascasse's anonymized search-behavior signals. AbbVie, Moderna and Gilead lead the list with a combined estimated audience of 130,124 people. Across all 9 entries the average audience size is 21,196, and the largest, AbbVie, reaches around 53,946 people in Italy. Audience size is the estimated number of unique people in Italy who actively engage with each biotechnology company, derived from search demand signals. Rankings reflect search-behavior signals collected across Italy and are refreshed weekly.
Ranking
| Rank | Name | Audience size | Country share | Subtype | Category |
|---|---|---|---|---|---|
| 1 |  AbbVie |
53,946 | 2.5% | Biotechnology company | Health |
| 2 |  Moderna |
38,564 | 7.8% | Biotechnology company | Health |
| 3 |  Gilead |
37,614 | 3.6% | Biotechnology company | Health |
| 4 |  BionTech |
28,276 | 1.4% | Biotechnology company | Health |
| 5 |  Gilead Sciences |
16,826 | 2.4% | Biotechnology company | Health |
| 6 |  Genentech |
5,479 | 0.6% | Biotechnology company | Health |
| 7 |  Tecan Group |
4,251 | 2.6% | Biotechnology company | Business & Career |
| 8 |  Bachem Holding |
3,019 | 0.8% | Biotechnology company | Business & Career |
| 9 |  CureVac |
2,794 | 1.3% | Biotechnology company | Health |
Frequently asked questions
How is this Top 9 list compiled?
Rascasse aggregates anonymized search-behavior signals across Italy and ranks each biotechnology company by its estimated audience size. Only entries with at least 5 measured entities are listed.
How often is the list updated?
The ranking is refreshed weekly from the latest search-behavior data and re-published as a static page.
What is the largest biotechnology company in Italy?
AbbVie currently leads with an estimated audience of 53,946 people in Italy.
Methodology
Audience sizes are estimated from anonymized search-behavior signals across Italy. Lists below 5 entries are not published. See methodology for full details.